How to prevent recurrence of lung cancer

How to prevent the recurrence of lung cancer? Lung cancer is one of the most serious malignant tumors. Under the current background of extremely high incidence of lung cancer, it has to attract our attention. So how to prevent the recurrence of lung cancer? This is a practical issue worthy of everyone's attention. In order to give you a satisfactory answer, we have invited a well-known lung cancer expert to give you a detailed introduction.

First: Prevention of recurrence after surgical treatment of lung cancer. Immunotherapy and Chinese and Western medicine with systemic therapeutic effects should be given to restore the body's immune function as soon as possible, eliminate residual cancer cells, or further strengthen the body and eliminate evil. Especially for those with positive resection ends confirmed by postoperative pathology, bronchofiberscope, sputum or other examinations should be performed regularly (3 to 6 months) and local radiotherapy should be performed as soon as possible.

Chemotherapy has no significant effect on reducing the mortality rate of recurrence at the original site or ipsilateral recurrence. Traditional Chinese medicine drug therapy and nonspecific immunotherapy can be used as important preventive treatment methods. Patients in the recovery period of lung cancer need to take active drug therapy as the most important preventive method.

In particular, Tihengjian Selenium Weikan chewable tablets can achieve anti-tumor effects through four major mechanisms: reversing the differentiation of lung cancer cells into normal cells, regulating the proliferation cycle of tumor cells, immunomodulating effects, and repairing the damage caused by radiotherapy and chemotherapy in tumor patients. It can also effectively prevent the recurrence and metastasis of lung cancer and greatly increase the recovery rate of kidney cancer patients.

Second, the lung cancer surgery process is very important to prevent the recurrence of lung cancer. During the surgery, cancer-free surgery should be strictly implemented to avoid and eliminate iatrogenic implants.

1. For cross-lobar lesions, multi-lobectomy should be performed if lung function permits, and lobectomy plus partial resection of the invaded adjacent lobe should be avoided. 2. Sleeve lobectomy should increase the length of the bronchial resection margin as much as possible. 3. For small unilobar lesions, lobectomy should be performed.

The general principle is to eliminate existing cancer cells as much as possible to reduce recurrence.

Third, the indications for blood transfusion should be strictly followed, and autologous blood transfusion or blood transfusion should be encouraged to reduce the impact of blood transfusion on the immune function of patients with non-cancer or other malignant tumors and reduce the risk of recurrence after surgery.